association between the SGLT2 inhibitor, Invokana (canagliflozin), and bone fractures

You'll see new warnings about an association between the SGLT2 inhibitor, Invokana (canagliflozin), and bone fractures.

These fractures seem to occur most commonly in the upper extremities...and usually AREN'T preceded by a major traumatic event.

It's possible these fractures are related to falls due to hypotension...since SGLT2 inhibitors or "flozins" have a diuretic effect. Plus, Invokana may reduce bone mineral density.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote